Tenet Healthcare Corporation (NYSE:THC) Given Average Rating of “Buy” by Analysts

Posted by George Bondi on Aug 24th, 2026

Shares of Tenet Healthcare Corporation (NYSE:THC – Get Free Report) have been assigned a consensus recommendation of “Buy” from the twenty-one research firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $273.00.

THC has been the topic of several recent analyst reports. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday. Royal Bank Of Canada upped their price objective on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a report on Monday, July 27th. Raymond James Financial reiterated an “outperform” rating and issued a $285.00 target price on shares of Tenet Healthcare in a research report on Friday, August 14th. UBS Group boosted their price target on shares of Tenet Healthcare from $288.00 to $308.00 and gave the stock a “buy” rating in a research report on Monday, July 27th. Finally, Morgan Stanley upped their price target on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday, July 27th.

Get Our Latest Stock Analysis on THC

Tenet Healthcare Trading Down 0.1%

Tenet Healthcare stock opened at $280.60 on Monday. Tenet Healthcare has a 52-week low of $157.58 and a 52-week high of $280.89. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The firm has a market capitalization of $22.59 billion, a price-to-earnings ratio of 10.82, a PEG ratio of 1.07 and a beta of 1.23. The firm has a 50-day moving average price of $220.53 and a two-hundred day moving average price of $206.93.

Tenet Healthcare (NYSE:THC – Get Free Report) last announced its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating the consensus estimate of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. Tenet Healthcare’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business earned $4.02 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Sell-side analysts expect that Tenet Healthcare will post 20.97 earnings per share for the current year.

Insider Transactions at Tenet Healthcare

In other news, Director Roy Blunt sold 600 shares of the company’s stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $262.68, for a total value of $157,608.00. Following the completion of the sale, the director owned 4,589 shares in the company, valued at $1,205,438.52. This represents a 11.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Paola M. Arbour sold 10,878 shares of the firm’s stock in a transaction dated Monday, July 27th. The shares were sold at an average price of $243.90, for a total value of $2,653,144.20. Following the transaction, the executive vice president directly owned 18,413 shares of the company’s stock, valued at $4,490,930.70. This represents a 37.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 41,375 shares of company stock valued at $9,793,347 over the last three months. 0.97% of the stock is owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

Several large investors have recently made changes to their positions in the business. Compass Financial Management LLC bought a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $57,000. AlphaGrep UK Ltd bought a new stake in shares of Tenet Healthcare in the 2nd quarter worth approximately $344,000. BAM Wealth Management LLC boosted its holdings in Tenet Healthcare by 73.1% during the second quarter. BAM Wealth Management LLC now owns 2,421 shares of the company’s stock worth $453,000 after buying an additional 1,022 shares in the last quarter. denkapparat Operations GmbH grew its position in Tenet Healthcare by 37.6% in the second quarter. denkapparat Operations GmbH now owns 3,716 shares of the company’s stock worth $695,000 after buying an additional 1,016 shares during the last quarter. Finally, Pale Fire Capital SE bought a new position in shares of Tenet Healthcare in the second quarter valued at $374,000. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.